Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib

A subset of patients with differentiated thyroid carcinoma develop radioiodine refractory (RAIR) incurable disease, which typically has a poor prognosis. The multitargeted tyrosine kinase inhibitor lenvatinib has demonstrated significant improvements in progression-free survival in RAIR thyroid canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukrithan, Vineeth, Kim, Lisa, Sipos, Jennifer A., Goyal, Ashima, Zhou, Ye, Addison, Daniel, Shah, Manisha, Konda, Bhavana, Vallakati, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629999/
https://www.ncbi.nlm.nih.gov/pubmed/37941892
http://dx.doi.org/10.1155/2023/8841696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629999/
https://www.ncbi.nlm.nih.gov/pubmed/37941892
http://dx.doi.org/10.1155/2023/8841696

Ejemplares similares